Sable raised $773.8 million in gross equity proceeds in 2024 and ended the year with 89,310,996 shares of common stock outstanding. During the year, the company received approval ...

This development is seen as a significant step forward for Sable Offshore, as it clears the way for the company to address pipeline anomalies and maintain the integrity of its infrastructure.

Exelixis (EXEL) announced that preclinical data will be presented for four pipeline molecules at the American Association for ...

Sable Offshore Corp. ("Sable," or the "Company") (NYSE: SOC) today announced its 2024 financial and operational results. 2024 Financial H ...